{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:57:40Z","timestamp":1794844660490,"version":"4.9.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gansu Provincial Joint Research Fund Project","award":["23JRRA1490"],"award-info":[{"award-number":["23JRRA1490"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFC3503400"],"award-info":[{"award-number":["2023YFC3503400"]}]},{"name":"14th Five-Year Plan Project","award":["2023YF2508305"],"award-info":[{"award-number":["2023YF2508305"]}]},{"name":"Integrated Traditional Chinese and Western Medicine Collaborative Chronic Disease Management Research Project","award":["CXZH2024082"],"award-info":[{"award-number":["CXZH2024082"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82560163"],"award-info":[{"award-number":["82560163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lanzhou University Innovation and Entrepreneurship training program","award":["20260060119"],"award-info":[{"award-number":["20260060119"]}]},{"name":"Cuiying Scholars Research Cultivation Program","award":["CYXZPT2025-31"],"award-info":[{"award-number":["CYXZPT2025-31"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01521-5","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:36:43Z","timestamp":1781073403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mitochondrial metabolic reprogramming drives diabetic kidney disease progression: cell-specific mechanisms, metabolic memory, and targeted strategies"],"prefix":"10.1186","volume":"32","author":[{"given":"Lingfei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"1521_CR1","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh, O., et al., PGC-1\u03b1 Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel). 2023;12(5).","DOI":"10.3390\/antiox12051075"},{"issue":"6","key":"1521_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00109-022-02204-4","volume":"100","author":"I Audzeyenka","year":"2022","unstructured":"Audzeyenka I, et al. PTEN-induced kinase 1 deficiency alters albumin permeability and insulin signaling in podocytes. J Mol Med (Berl). 2022;100(6):903\u201315.","journal-title":"J Mol Med (Berl)"},{"key":"1521_CR3","doi-asserted-by":"crossref","unstructured":"Bangar, N.S., et al., Syzygium cumini (L.) skeels mitigate diabetic nephropathy by regulating Nrf2 pathway and mitocyhondrial dysfunction: In vitro and in vivo studies. J Ethnopharmacol. 2025;336:118684.","DOI":"10.1016\/j.jep.2024.118684"},{"issue":"7947","key":"1521_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-05661-6","volume":"614","author":"CR Bartman","year":"2023","unstructured":"Bartman CR, et al. Slow TCA flux and ATP production in primary solid tumours but not metastases. Nature. 2023;614(7947):349\u201357.","journal-title":"Nature"},{"issue":"2","key":"1521_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/15548627.2022.2080382","volume":"19","author":"F Barutta","year":"2023","unstructured":"Barutta F, et al. Protective effect of the tunneling nanotube-TNFAIP2\/M-sec system on podocyte autophagy in diabetic nephropathy. Autophagy. 2023;19(2):505\u201324.","journal-title":"Autophagy"},{"issue":"1","key":"1521_CR6","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1038\/s41467-024-47174-y","volume":"15","author":"LKM Blomgren","year":"2024","unstructured":"Blomgren LKM, et al. Dynamic inter-domain transformations mediate the allosteric regulation of human 5, 10-methylenetetrahydrofolate reductase. Nat Commun. 2024;15(1):3248.","journal-title":"Nat Commun"},{"issue":"6","key":"1521_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","volume":"85","author":"HK Bryan","year":"2013","unstructured":"Bryan HK, et al. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol. 2013;85(6):705\u201317.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1521_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1172\/JCI74942","volume":"125","author":"M Bueno","year":"2015","unstructured":"Bueno M, et al. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest. 2015;125(2):521\u201338.","journal-title":"J Clin Invest"},{"issue":"10","key":"1521_CR9","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1083\/jcb.201612106","volume":"216","author":"JL Burman","year":"2017","unstructured":"Burman JL, et al. Mitochondrial fission facilitates the selective mitophagy of protein aggregates. J Cell Biol. 2017;216(10):3231\u201347.","journal-title":"J Cell Biol"},{"key":"1521_CR10","doi-asserted-by":"publisher","first-page":"154959","DOI":"10.1016\/j.metabol.2021.154959","volume":"128","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Adiponectin promotes repair of renal tubular epithelial cells by regulating mitochondrial biogenesis and function. Metabolism. 2022;128:154959.","journal-title":"Metabolism"},{"issue":"1","key":"1521_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8(1):333.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1521_CR12","doi-asserted-by":"publisher","first-page":"2521455","DOI":"10.1080\/0886022X.2025.2521455","volume":"47","author":"T Chen","year":"2025","unstructured":"Chen T, et al. METTL3 alleviates renal tubular mitochondrial dysfunction by regulating the TUG1\/PGC-1a axis in an IGF2BP2-dependent manner in diabetic nephropathy. Ren Fail. 2025;47(1):2521455.","journal-title":"Ren Fail"},{"key":"1521_CR13","doi-asserted-by":"crossref","unstructured":"Chen, H.M., et al., RCAN1.4 mediates high glucose-induced matrix production by stimulating mitochondrial fission in mesangial cells. Biosci Rep. 2020;40(1).","DOI":"10.1042\/BSR20192759"},{"key":"1521_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fphys.2020.00794","volume":"11","author":"L Console","year":"2020","unstructured":"Console L, et al. The link between the mitochondrial fatty acid oxidation derangement and kidney injury. Front Physiol. 2020;11:794.","journal-title":"Front Physiol"},{"issue":"11","key":"1521_CR15","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.2337\/diabetes.54.11.3095","volume":"54","author":"RJ Coward","year":"2005","unstructured":"Coward RJ, et al. The human glomerular podocyte is a novel target for insulin action. Diabetes. 2005;54(11):3095\u2013102.","journal-title":"Diabetes"},{"key":"1521_CR16","doi-asserted-by":"publisher","first-page":"102033","DOI":"10.1016\/j.redox.2021.102033","volume":"45","author":"X Dai","year":"2021","unstructured":"Dai X, et al. Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Redox Biol. 2021;45:102033.","journal-title":"Redox Biol"},{"issue":"15","key":"1521_CR17","doi-asserted-by":"publisher","first-page":"12378","DOI":"10.3390\/ijms241512378","volume":"24","author":"M Darenskaya","year":"2023","unstructured":"Darenskaya M, et al. Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies. Int J Mol Sci. 2023;24(15):12378.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1521_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-025-02311-x","volume":"10","author":"H Du","year":"2025","unstructured":"Du H, et al. Mitochondrial metabolism and cancer therapeutic innovation. Signal Transduct Target Ther. 2025;10(1):245.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"1521_CR19","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1172\/JCI125316","volume":"129","author":"GM Ducasa","year":"2019","unstructured":"Ducasa GM, et al. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. J Clin Invest. 2019;129(8):3387\u2013400.","journal-title":"J Clin Invest"},{"key":"1521_CR20","doi-asserted-by":"crossref","unstructured":"Duncan, B.B., D.J. Magliano, and E.J. Boyko, IDF diabetes atlas 11th edition 2025: global prevalence and projections for 2050. Nephrol Dial Transplant. 2025.","DOI":"10.1093\/ndt\/gfaf177"},{"issue":"5","key":"1521_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrneph.2015.214","volume":"12","author":"F Emma","year":"2016","unstructured":"Emma F, et al. Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol. 2016;12(5):267\u201380.","journal-title":"Nat Rev Nephrol"},{"issue":"19","key":"1521_CR22","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","volume":"40","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S. The functional roles of TCA cycle metabolites in cancer. Oncogene. 2021;40(19):3351\u201363.","journal-title":"Oncogene"},{"issue":"6","key":"1521_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","volume":"15","author":"X Fan","year":"2024","unstructured":"Fan X, et al. Mitochondrial metabolic reprogramming in diabetic kidney disease. Cell Death Dis. 2024;15(6):442.","journal-title":"Cell Death Dis"},{"issue":"15","key":"1521_CR24","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt SM. 100 years of the Warburg effect: a cancer metabolism endeavor. Cell. 2024;187(15):3824\u20138.","journal-title":"Cell"},{"key":"1521_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.trsl.2024.10.001","volume":"274","author":"Q Feng","year":"2024","unstructured":"Feng Q, et al. RXR\u03b1\/MR signaling promotes diabetic kidney disease by facilitating renal tubular epithelial cells senescence and metabolic reprogramming. Transl Res. 2024;274:101\u201317.","journal-title":"Transl Res"},{"key":"1521_CR26","doi-asserted-by":"publisher","first-page":"112029","DOI":"10.1016\/j.cellsig.2025.112029","volume":"135","author":"J Feng","year":"2025","unstructured":"Feng J, et al. SIRT3 deficiency aggravates mitochondrial metabolic disorder and podocyte injury in DKD via MPC2 acetylation. Cell Signal. 2025;135:112029.","journal-title":"Cell Signal"},{"issue":"1","key":"1521_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7(1):376.","journal-title":"Signal Transduct Target Ther"},{"key":"1521_CR28","doi-asserted-by":"publisher","first-page":"155247","DOI":"10.1016\/j.phymed.2023.155247","volume":"123","author":"M Gong","year":"2024","unstructured":"Gong M, et al. Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis. Phytomedicine. 2024;123:155247.","journal-title":"Phytomedicine"},{"issue":"5","key":"1521_CR29","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1042\/BST20240319","volume":"52","author":"S Goyani","year":"2024","unstructured":"Goyani S, et al. Calcium signaling in mitochondrial intermembrane space. Biochem Soc Trans. 2024;52(5):2215\u201329.","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"1521_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s42255-023-00771-5","volume":"5","author":"AC Green","year":"2023","unstructured":"Green AC, et al. Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells. Nat Metab. 2023;5(4):642\u201359.","journal-title":"Nat Metab"},{"issue":"12","key":"1521_CR31","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1093\/ndt\/gfad173","volume":"38","author":"Z Guo","year":"2023","unstructured":"Guo Z, et al. Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease. Nephrol Dial Transplant. 2023;38(12):2754\u201366.","journal-title":"Nephrol Dial Transplant"},{"issue":"37","key":"1521_CR32","doi-asserted-by":"publisher","first-page":"e12034","DOI":"10.1002\/advs.202412034","volume":"12","author":"Z Guo","year":"2025","unstructured":"Guo Z, et al. Engineered RGD-Treg-Exos targeted delivery of miR-218-5p to activate mitophagy and attenuate podocyte injury in diabetic kidney disease. Adv Sci (Weinh). 2025;12(37):e12034.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"1521_CR33","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","volume":"107","author":"S Gupta","year":"2023","unstructured":"Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am. 2023;107(4):689\u2013705.","journal-title":"Med Clin North Am"},{"key":"1521_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226772","author":"P Gupta","year":"2024","unstructured":"Gupta P, et al. Metabolic chaos in kidney disease: unraveling energy dysregulation. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13226772.","journal-title":"J Clin Med"},{"issue":"Pt A","key":"1521_CR35","doi-asserted-by":"publisher","first-page":"115923","DOI":"10.1016\/j.jep.2022.115923","volume":"302","author":"Y Han","year":"2023","unstructured":"Han Y, et al. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36\/TRPC6\/NFAT2 signaling in type 2 diabetes mellitus mice. J Ethnopharmacol. 2023;302(Pt A):115923.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"1521_CR36","doi-asserted-by":"publisher","first-page":"168131","DOI":"10.1016\/j.bbadis.2025.168131","volume":"1872","author":"Q Han","year":"2026","unstructured":"Han Q, et al. CD4+ T-cell-derived small extracellular vesicles induce the apoptosis of renal tubular epithelial cells in diabetic nephropathy by regulating mitochondrial dynamics. Biochim Biophys Acta Mol Basis Dis. 2026;1872(3):168131.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"1521_CR37","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","volume":"103","author":"JS Harrington","year":"2023","unstructured":"Harrington JS, et al. Mitochondria in health, disease, and aging. Physiol Rev. 2023;103(4):2349\u2013422.","journal-title":"Physiol Rev"},{"issue":"3","key":"1521_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"M Herman-Edelstein","year":"2014","unstructured":"Herman-Edelstein M, et al. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res. 2014;55(3):561\u201372.","journal-title":"J Lipid Res"},{"issue":"9","key":"1521_CR39","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3390\/nu14091987","volume":"14","author":"M Hole\u010dek","year":"2022","unstructured":"Hole\u010dek M. Serine metabolism in health and disease and as a conditionally essential amino acid. Nutrients. 2022;14(9):1987.","journal-title":"Nutrients"},{"issue":"3","key":"1521_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/kidneydial2030038","volume":"2","author":"EK Hoogeveen","year":"2022","unstructured":"Hoogeveen EK. The epidemiology of diabetic kidney disease. Kidney Dial. 2022;2(3):433\u201342.","journal-title":"Kidney Dial"},{"key":"1521_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-physiol-042222-025000","volume":"86","author":"CA Hoogstraten","year":"2024","unstructured":"Hoogstraten CA, Hoenderop JG, de Baaij JHF. Mitochondrial dysfunction in kidney tubulopathies. Annu Rev Physiol. 2024;86:379\u2013403.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"1521_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00018-023-05078-y","volume":"81","author":"Y Hou","year":"2024","unstructured":"Hou Y, et al. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney. Cell Mol Life Sci. 2024;81(1):23.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1521_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/15548627.2025.2581214","volume":"22","author":"H Hu","year":"2026","unstructured":"Hu H, et al. XIAP-ULK1-mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease. Autophagy. 2026;22(1):207\u201328.","journal-title":"Autophagy"},{"issue":"4","key":"1521_CR44","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1080\/15548627.2025.2601874","volume":"22","author":"H Hu","year":"2026","unstructured":"Hu H, et al. ESRRA-ATG5-mediated mitophagy enhances arginine metabolism to alleviate diabetic kidney disease. Autophagy. 2026;22(4):666\u201390.","journal-title":"Autophagy"},{"issue":"1","key":"1521_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8(1):129.","journal-title":"Signal Transduct Target Ther"},{"key":"1521_CR46","doi-asserted-by":"crossref","unstructured":"Huang, S., et al., Nepeta angustifolia C. Y. Wu improves renal injury in HFD\/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells. J Ethnopharmacol. 2020. 255:112771.","DOI":"10.1016\/j.jep.2020.112771"},{"key":"1521_CR47","doi-asserted-by":"crossref","unstructured":"Huang, Q., et al., Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice. Adv Sci (Weinh), 2025: p. e03259.","DOI":"10.1002\/advs.202503259"},{"issue":"2","key":"1521_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41581-022-00648-y","volume":"19","author":"C Huynh","year":"2023","unstructured":"Huynh C, et al. Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases. Nat Rev Nephrol. 2023;19(2):102\u201322.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"1521_CR49","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s10753-023-01940-0","volume":"47","author":"H Ji","year":"2024","unstructured":"Ji H, et al. Upregulation of UHRF1 promotes PINK1-mediated mitophagy to alleviates ferroptosis in diabetic nephropathy. Inflammation. 2024;47(2):718\u201332.","journal-title":"Inflammation"},{"issue":"1","key":"1521_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s10020-022-00525-1","volume":"28","author":"Y Jia","year":"2022","unstructured":"Jia Y, et al. Tubular epithelial cell-derived extracellular vesicles induce macrophage glycolysis by stabilizing HIF-1\u03b1 in diabetic kidney disease. Mol Med. 2022;28(1):95.","journal-title":"Mol Med"},{"key":"1521_CR51","doi-asserted-by":"publisher","first-page":"868127","DOI":"10.3389\/fimmu.2022.868127","volume":"13","author":"S Jiang","year":"2022","unstructured":"Jiang S, et al. Complement deposition predicts worsening kidney function and underlines the clinical significance of the 2010 Renal Pathology Society classification of diabetic nephropathy. Front Immunol. 2022;13:868127.","journal-title":"Front Immunol"},{"issue":"7","key":"1521_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/md18070363","volume":"18","author":"L Jin","year":"2020","unstructured":"Jin L, et al. Tilapia skin peptides ameliorate diabetic nephropathy in STZ-Induced Diabetic Rats and HG-Induced GMCs by Improving Mitochondrial Dysfunction. Mar Drugs. 2020;18(7):363.","journal-title":"Mar Drugs"},{"issue":"26","key":"1521_CR53","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1073\/pnas.2000943117","volume":"117","author":"C Jing","year":"2020","unstructured":"Jing C, et al. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc Natl Acad Sci U S A. 2020;117(26):15160\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1521_CR54","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.kint.2023.09.019","volume":"104","author":"K Kanasaki","year":"2023","unstructured":"Kanasaki K. The aberrant glycolysis in kidney proximal tubule: potential therapeutic target for DKD. Kidney Int. 2023;104(6):1056\u20139.","journal-title":"Kidney Int"},{"key":"1521_CR55","doi-asserted-by":"publisher","first-page":"155982","DOI":"10.1016\/j.metabol.2024.155982","volume":"159","author":"JS Kang","year":"2024","unstructured":"Kang JS, et al. RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling. Metabolism. 2024;159:155982.","journal-title":"Metabolism"},{"issue":"2","key":"1521_CR56","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4049\/jimmunol.1600265","volume":"197","author":"K Kobayashi","year":"2016","unstructured":"Kobayashi K, et al. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis. J Immunol. 2016;197(2):504\u201316.","journal-title":"J Immunol"},{"issue":"6904","key":"1521_CR57","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature01036","volume":"419","author":"GJ Kops","year":"2002","unstructured":"Kops GJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419(6904):316\u201321.","journal-title":"Nature"},{"issue":"24","key":"1521_CR58","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/ijms222413384","volume":"22","author":"P Kowalczyk","year":"2021","unstructured":"Kowalczyk P, et al. Mitochondrial oxidative stress-a causative factor and therapeutic target in many diseases. Int J Mol Sci. 2021;22(24):13384.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1521_CR59","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.immuni.2016.01.001","volume":"44","author":"JL Larson-Casey","year":"2016","unstructured":"Larson-Casey JL, et al. Macrophage Akt1 kinase-mediated mitophagy modulates apoptosis resistance and pulmonary fibrosis. Immunity. 2016;44(3):582\u201396.","journal-title":"Immunity"},{"issue":"40","key":"1521_CR60","doi-asserted-by":"publisher","first-page":"28668","DOI":"10.1074\/jbc.M113.470971","volume":"288","author":"DY Lee","year":"2013","unstructured":"Lee DY, et al. Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: role of mitochondrial reactive oxygen species. J Biol Chem. 2013;288(40):28668\u201386.","journal-title":"J Biol Chem"},{"key":"1521_CR61","doi-asserted-by":"publisher","first-page":"104600","DOI":"10.1016\/j.phrs.2019.104600","volume":"152","author":"J Lee","year":"2020","unstructured":"Lee J, et al. Mitochondrial carnitine palmitoyltransferase 2 is involved in N(\u03b5)-(carboxymethyl)-lysine-mediated diabetic nephropathy. Pharmacol Res. 2020;152:104600.","journal-title":"Pharmacol Res"},{"issue":"7","key":"1521_CR62","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/15548627.2015.1049799","volume":"11","author":"O Lenoir","year":"2015","unstructured":"Lenoir O, et al. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. Autophagy. 2015;11(7):1130\u201345.","journal-title":"Autophagy"},{"issue":"7","key":"1521_CR63","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1210\/en.2016-1970","volume":"158","author":"W Li","year":"2017","unstructured":"Li W, et al. FoxO1 promotes mitophagy in the podocytes of diabetic male mice via the PINK1\/Parkin pathway. Endocrinology. 2017;158(7):2155\u201367.","journal-title":"Endocrinology"},{"issue":"2","key":"1521_CR64","doi-asserted-by":"publisher","first-page":"e48781","DOI":"10.15252\/embr.201948781","volume":"21","author":"J Li","year":"2020","unstructured":"Li J, et al. Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS. EMBO Rep. 2020;21(2):e48781.","journal-title":"EMBO Rep"},{"issue":"8","key":"1521_CR65","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.34067\/KID.0000000000000153","volume":"4","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Energy metabolism dysregulation in chronic kidney disease. Kidney360. 2023;4(8):1080\u201394.","journal-title":"Kidney360"},{"key":"1521_CR66","doi-asserted-by":"publisher","first-page":"155378","DOI":"10.1016\/j.metabol.2022.155378","volume":"139","author":"S Li","year":"2023","unstructured":"Li S, et al. Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis. Metabolism. 2023;139:155378.","journal-title":"Metabolism"},{"key":"1521_CR67","doi-asserted-by":"publisher","first-page":"1453365","DOI":"10.3389\/fcell.2024.1453365","volume":"12","author":"K Li","year":"2024","unstructured":"Li K, Xia X, Tong Y. Multiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney disease. Front Cell Dev Biol. 2024;12:1453365.","journal-title":"Front Cell Dev Biol"},{"key":"1521_CR68","doi-asserted-by":"publisher","first-page":"157164","DOI":"10.1016\/j.phymed.2025.157164","volume":"147","author":"H Li","year":"2025","unstructured":"Li H, et al. Schisandra chinensis mixture attenuates diabetic kidney disease via VDAC1\/Grp75\/IP(3)R-mediated MAMs stabilization and apoptosis-autophagy regulation. Phytomedicine. 2025;147:157164.","journal-title":"Phytomedicine"},{"issue":"2","key":"1521_CR69","doi-asserted-by":"publisher","first-page":"e70256","DOI":"10.1002\/jcsm.70256","volume":"17","author":"Y Li","year":"2026","unstructured":"Li Y, et al. IL-15 links muscle-kidney crosstalk to preserving podocyte mitochondrial fusion and attenuating diabetic nephropathy. J Cachexia Sarcopenia Muscle. 2026;17(2):e70256.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8061","key":"1521_CR70","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41586-025-08873-8","volume":"641","author":"J Liang","year":"2025","unstructured":"Liang J, et al. Structures and mechanism of the human mitochondrial pyruvate carrier. Nature. 2025;641(8061):258\u201365.","journal-title":"Nature"},{"issue":"8","key":"1521_CR71","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.3390\/ijms25084350","volume":"25","author":"DW Lin","year":"2024","unstructured":"Lin DW, et al. Targeting macrophages: therapeutic approaches in diabetic kidney disease. Int J Mol Sci. 2024;25(8):4350.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1521_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cells13010023","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. NLRX1 prevents M2 macrophage polarization and excessive renal fibrosis in chronic obstructive nephropathy. Cells. 2023;13(1):23.","journal-title":"Cells"},{"issue":"12","key":"1521_CR73","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.7150\/ijbs.93506","volume":"20","author":"J Liu","year":"2024","unstructured":"Liu J, et al. MicroRNA-29b plays a vital role in podocyte injury and glomerular diseases through inducing mitochondrial dysfunction. Int J Biol Sci. 2024;20(12):4654\u201373.","journal-title":"Int J Biol Sci"},{"key":"1521_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2025.08.019","volume":"240","author":"M Liu","year":"2025","unstructured":"Liu M, et al. Novel coumarin derivative SZC-6 as an allosteric activator of SIRT3 alleviates diabetic kidney disease via the SIRT3-Foxo3a signaling axis. Free Radic Biol Med. 2025;240:29\u201345.","journal-title":"Free Radic Biol Med"},{"issue":"Pt A","key":"1521_CR75","doi-asserted-by":"publisher","first-page":"120613","DOI":"10.1016\/j.jep.2025.120613","volume":"355","author":"X Liu","year":"2026","unstructured":"Liu X, et al. Mechanistic insights into myricetin-regulated autophagy via the PI3K\/Akt and PINK1\/Parkin pathway in diabetic kidney disease treatment. J Ethnopharmacol. 2026;355(Pt A):120613.","journal-title":"J Ethnopharmacol"},{"key":"1521_CR76","doi-asserted-by":"crossref","unstructured":"Lozoya, O.A., et al., Mitochondrial acetyl-CoA reversibly regulates locus-specific histone acetylation and gene expression. Life Sci Alliance. 2019;2(1).","DOI":"10.26508\/lsa.201800228"},{"issue":"1","key":"1521_CR77","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12967-022-03629-8","volume":"20","author":"YP Lu","year":"2022","unstructured":"Lu YP, et al. SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease. J Transl Med. 2022;20(1):420.","journal-title":"J Transl Med"},{"issue":"1","key":"1521_CR78","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41420-025-02650-2","volume":"11","author":"X Lu","year":"2025","unstructured":"Lu X, et al. P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism. Cell Death Discov. 2025;11(1):355.","journal-title":"Cell Death Discov"},{"issue":"1","key":"1521_CR79","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2022.2146512","volume":"45","author":"X Ma","year":"2023","unstructured":"Ma X, et al. Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention. Ren Fail. 2023;45(1):2146512.","journal-title":"Ren Fail"},{"issue":"6642","key":"1521_CR80","doi-asserted-by":"publisher","first-page":"eabj5559","DOI":"10.1126\/science.abj5559","volume":"380","author":"N Malik","year":"2023","unstructured":"Malik N, et al. Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1. Science. 2023;380(6642):eabj5559.","journal-title":"Science"},{"key":"1521_CR81","doi-asserted-by":"crossref","unstructured":"Martinez Leon, V., R. Hilburg, and K. Susztak, Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Rev Endocrinol. 2025.","DOI":"10.1038\/s41574-025-01171-3"},{"issue":"4","key":"1521_CR82","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/db15-1231","volume":"65","author":"A Mehlem","year":"2016","unstructured":"Mehlem A, et al. PGC-1\u03b1 Coordinates Mitochondrial Respiratory Capacity and Muscular Fatty Acid Uptake via Regulation of VEGF-B. Diabetes. 2016;65(4):861\u201373.","journal-title":"Diabetes"},{"issue":"3","key":"1521_CR83","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.kint.2024.10.031","volume":"107","author":"I Mimura","year":"2025","unstructured":"Mimura I, Chen Z, Natarajan R. Epigenetic alterations and memory: key players in the development\/progression of chronic kidney disease promoted by acute kidney injury and diabetes. Kidney Int. 2025;107(3):434\u201356.","journal-title":"Kidney Int"},{"issue":"1","key":"1521_CR84","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1038\/s41467-024-46366-w","volume":"15","author":"K Mise","year":"2024","unstructured":"Mise K, et al. NDUFS4 regulates cristae remodeling in diabetic kidney disease. Nat Commun. 2024;15(1):1965.","journal-title":"Nat Commun"},{"issue":"5","key":"1521_CR85","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4239\/wjd.v12.i5.524","volume":"12","author":"A Mitrofanova","year":"2021","unstructured":"Mitrofanova A, et al. New insights into renal lipid dysmetabolism in diabetic kidney disease. World J Diabetes. 2021;12(5):524\u201340.","journal-title":"World J Diabetes"},{"issue":"10","key":"1521_CR86","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19(10):629\u201345.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1521_CR87","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.kint.2022.04.021","volume":"102","author":"Y Nagai","year":"2022","unstructured":"Nagai Y, et al. Rho-associated, coiled-coil-containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism. Kidney Int. 2022;102(3):536\u201345.","journal-title":"Kidney Int"},{"issue":"11","key":"1521_CR88","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3390\/antiox10111824","volume":"10","author":"G Napolitano","year":"2021","unstructured":"Napolitano G, Fasciolo G, Venditti P. Mitochondrial management of reactive oxygen species. Antioxidants (Basel). 2021;10(11):1824.","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"1521_CR89","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1530\/EC-12-0053","volume":"1","author":"RP Narayanan","year":"2012","unstructured":"Narayanan RP, et al. IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes. Endocr Connect. 2012;1(2):95\u2013102.","journal-title":"Endocr Connect"},{"issue":"10","key":"1521_CR90","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra DP, Youle RJ. The role of PINK1-Parkin in mitochondrial quality control. Nat Cell Biol. 2024;26(10):1639\u201351.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"1521_CR91","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2337\/dbi20-0030","volume":"70","author":"R Natarajan","year":"2021","unstructured":"Natarajan R. Epigenetic mechanisms in diabetic vascular complications and metabolic memory: the 2020 Edwin Bierman award lecture. Diabetes. 2021;70(2):328\u201337.","journal-title":"Diabetes"},{"issue":"6","key":"1521_CR92","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145\u201359.","journal-title":"Cell"},{"issue":"1","key":"1521_CR93","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/14756366.2021.2024526","volume":"37","author":"Y Pan","year":"2022","unstructured":"Pan Y, et al. Research progress of coumarins and their derivatives in the treatment of diabetes. J Enzyme Inhib Med Chem. 2022;37(1):616\u201328.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"1521_CR94","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1105351","volume":"365","author":"PE Pergola","year":"2011","unstructured":"Pergola PE, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med. 2011;365(4):327\u201336.","journal-title":"N Engl J Med"},{"issue":"4","key":"1521_CR95","doi-asserted-by":"publisher","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","volume":"312","author":"R Pichler","year":"2017","unstructured":"Pichler R, et al. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Renal Physiol. 2017;312(4):F716-f731.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"1521_CR96","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41580-019-0180-9","volume":"21","author":"WA Prinz","year":"2020","unstructured":"Prinz WA, Toulmay A, Balla T. The functional universe of membrane contact sites. Nat Rev Mol Cell Biol. 2020;21(1):7\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1521_CR97","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2337\/db08-0061","volume":"57","author":"Y Qian","year":"2008","unstructured":"Qian Y, et al. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes. 2008;57(6):1439\u201345.","journal-title":"Diabetes"},{"issue":"4","key":"1521_CR98","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2016.23","volume":"17","author":"PM Quir\u00f3s","year":"2016","unstructured":"Quir\u00f3s PM, Mottis A, Auwerx J. Mitonuclear communication in homeostasis and stress. Nat Rev Mol Cell Biol. 2016;17(4):213\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1521_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tcb.2024.05.001","volume":"35","author":"O Rackham","year":"2025","unstructured":"Rackham O, et al. Unique architectural features of mammalian mitochondrial protein synthesis. Trends Cell Biol. 2025;35(1):11\u201323.","journal-title":"Trends Cell Biol"},{"issue":"11","key":"1521_CR100","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1042\/CS20190764","volume":"134","author":"PA Reynolds","year":"2020","unstructured":"Reynolds PA. The mechanobiology of kidney podocytes in health and disease. Clin Sci (Lond). 2020;134(11):1245\u201353.","journal-title":"Clin Sci (Lond)"},{"key":"1521_CR101","doi-asserted-by":"publisher","first-page":"729384","DOI":"10.3389\/fphar.2021.729384","volume":"12","author":"Q Rong","year":"2021","unstructured":"Rong Q, et al. Berberine reduces lipid accumulation by promoting fatty acid oxidation in renal tubular epithelial cells of the diabetic kidney. Front Pharmacol. 2021;12:729384.","journal-title":"Front Pharmacol"},{"key":"1521_CR102","doi-asserted-by":"publisher","first-page":"746151","DOI":"10.3389\/fimmu.2021.746151","volume":"12","author":"S Russo","year":"2021","unstructured":"Russo S, et al. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol. 2021;12:746151.","journal-title":"Front Immunol"},{"key":"1521_CR103","doi-asserted-by":"publisher","first-page":"175866","DOI":"10.1016\/j.ejphar.2023.175866","volume":"953","author":"MS Sarwar","year":"2023","unstructured":"Sarwar MS, et al. Metabolic rewiring and epigenetic reprogramming in leptin receptor-deficient db\/db diabetic nephropathy mice. Eur J Pharmacol. 2023;953:175866.","journal-title":"Eur J Pharmacol"},{"issue":"15","key":"1521_CR104","doi-asserted-by":"publisher","first-page":"e86976","DOI":"10.1172\/jci.insight.86976","volume":"1","author":"KM Sas","year":"2016","unstructured":"Sas KM, et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight. 2016;1(15):e86976.","journal-title":"JCI Insight"},{"issue":"4","key":"1521_CR105","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/ijms22041546","volume":"22","author":"C S\u00e1vio-Silva","year":"2021","unstructured":"S\u00e1vio-Silva C, et al. Therapeutic potential of mesenchymal stem cells in a pre-clinical model of diabetic kidney disease and obesity. Int J Mol Sci. 2021;22(4):1546.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1521_CR106","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","volume":"163","author":"GS Shadel","year":"2015","unstructured":"Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis. Cell. 2015;163(3):560\u20139.","journal-title":"Cell"},{"issue":"2","key":"1521_CR107","first-page":"Cd006800","volume":"2012","author":"D Shan","year":"2012","unstructured":"Shan D, et al. Pentoxifylline for diabetic kidney disease. Cochrane Database Syst Rev. 2012;2012(2):Cd006800.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1521_CR108","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s00125-023-06078-0","volume":"67","author":"M Shao","year":"2024","unstructured":"Shao M, et al. Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns. Diabetologia. 2024;67(4):738\u201354.","journal-title":"Diabetologia"},{"key":"1521_CR109","doi-asserted-by":"publisher","first-page":"937247","DOI":"10.3389\/fimmu.2022.937247","volume":"13","author":"J Shi","year":"2022","unstructured":"Shi J, Cai C. Research progress on the mechanism of Itaconate regulating macrophage immunometabolism. Front Immunol. 2022;13:937247.","journal-title":"Front Immunol"},{"issue":"1","key":"1521_CR110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41580-020-00300-2","volume":"22","author":"J Song","year":"2021","unstructured":"Song J, Herrmann JM, Becker T. Quality control of the mitochondrial proteome. Nat Rev Mol Cell Biol. 2021;22(1):54\u201370.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"1521_CR111","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41419-022-04803-y","volume":"13","author":"C Song","year":"2022","unstructured":"Song C, et al. IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis. Cell Death Dis. 2022;13(4):340.","journal-title":"Cell Death Dis"},{"issue":"5","key":"1521_CR112","doi-asserted-by":"publisher","first-page":"102390","DOI":"10.1016\/j.isci.2021.102390","volume":"24","author":"SP Srivastava","year":"2021","unstructured":"Srivastava SP, et al. Endothelial SIRT3 regulates myofibroblast metabolic shifts in diabetic kidneys. iScience. 2021;24(5):102390.","journal-title":"iScience"},{"issue":"1","key":"1521_CR113","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s41467-021-22617-y","volume":"12","author":"SP Srivastava","year":"2021","unstructured":"Srivastava SP, et al. Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nat Commun. 2021;12(1):2368.","journal-title":"Nat Commun"},{"issue":"14","key":"1521_CR114","doi-asserted-by":"publisher","first-page":"e104105","DOI":"10.15252\/embj.2019104105","volume":"39","author":"T Stephan","year":"2020","unstructured":"Stephan T, et al. MICOS assembly controls mitochondrial inner membrane remodeling and crista junction redistribution to mediate cristae formation. EMBO J. 2020;39(14):e104105.","journal-title":"EMBO J"},{"issue":"16","key":"1521_CR115","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.7150\/ijbs.83906","volume":"19","author":"MJ Sung","year":"2023","unstructured":"Sung MJ, et al. PTEN-induced kinase 1 exerts protective effects in diabetic kidney disease by attenuating mitochondrial dysfunction and necroptosis. Int J Biol Sci. 2023;19(16):5145\u201359.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"1521_CR116","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41580-024-00785-1","volume":"26","author":"LC T\u00e1bara","year":"2025","unstructured":"T\u00e1bara LC, Segawa M, Prudent J. Molecular mechanisms of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2025;26(2):123\u201346.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"1521_CR117","doi-asserted-by":"publisher","first-page":"e186836","DOI":"10.1172\/jci.insight.186836","volume":"10","author":"CL Tamargo","year":"2025","unstructured":"Tamargo CL, et al. The distal nephron biomarkers associate with diabetic kidney disease progression. JCI Insight. 2025;10(12):e186836.","journal-title":"JCI Insight"},{"issue":"3","key":"1521_CR118","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cmet.2016.07.002","volume":"24","author":"T TeSlaa","year":"2016","unstructured":"TeSlaa T, et al. \u03b1-Ketoglutarate accelerates the initial differentiation of primed human pluripotent stem cells. Cell Metab. 2016;24(3):485\u201393.","journal-title":"Cell Metab"},{"issue":"9","key":"1521_CR119","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4239\/wjd.v6.i9.1113","volume":"6","author":"TA VanderJagt","year":"2015","unstructured":"VanderJagt TA, et al. Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy. World J Diabetes. 2015;6(9):1113\u201321.","journal-title":"World J Diabetes"},{"issue":"1","key":"1521_CR120","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, et al. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36\u201350.","journal-title":"Cell Metab"},{"issue":"26","key":"1521_CR121","doi-asserted-by":"publisher","first-page":"23742","DOI":"10.1074\/jbc.M102348200","volume":"276","author":"N Wang","year":"2001","unstructured":"Wang N, et al. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem. 2001;276(26):23742\u20137.","journal-title":"J Biol Chem"},{"issue":"7","key":"1521_CR122","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/jid.2014.84","volume":"134","author":"YW Wang","year":"2014","unstructured":"Wang YW, et al. siRNA-targeting transforming growth factor-\u03b2 type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue. J Invest Dermatol. 2014;134(7):2016\u201325.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1521_CR123","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-020-20315-9","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages. Nat Commun. 2021;12(1):102.","journal-title":"Nat Commun"},{"issue":"15","key":"1521_CR124","doi-asserted-by":"publisher","first-page":"7881","DOI":"10.3390\/ijms22157881","volume":"22","author":"L Wang","year":"2021","unstructured":"Wang L, et al. TGF-beta as a master regulator of diabetic nephropathy. Int J Mol Sci. 2021;22(15):7881.","journal-title":"Int J Mol Sci"},{"issue":"7\u20138","key":"1521_CR125","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10495-024-01974-1","volume":"29","author":"X Wang","year":"2024","unstructured":"Wang X, et al. IGFBP2 induces podocyte apoptosis promoted by mitochondrial damage via integrin \u03b15\/FAK in diabetic kidney disease. Apoptosis. 2024;29(7\u20138):1109\u201325.","journal-title":"Apoptosis"},{"key":"1521_CR126","doi-asserted-by":"publisher","first-page":"115641","DOI":"10.1016\/j.intimp.2025.115641","volume":"166","author":"H Wang","year":"2025","unstructured":"Wang H, et al. Mitochondrial protease ClpP deficiency protects against tubulointerstitial damage in diabetic kidney disease. Int Immunopharmacol. 2025;166:115641.","journal-title":"Int Immunopharmacol"},{"key":"1521_CR127","doi-asserted-by":"crossref","unstructured":"Wang, S., et al., IGFBP-5\/TGF-\u03b21-mediated crosstalk between endothelial and tubular epithelial cells promotes interstitial fibrosis. Nephrol Dial Transplant. 2025.","DOI":"10.1093\/ndt\/gfaf179"},{"key":"1521_CR128","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5664","author":"M Weng","year":"2025","unstructured":"Weng M, et al. C3a\/C3aR axis is involved in diabetic kidney injury by regulating podocyte mitophagy in diabetic nephropathy. Int J Mol Med. 2025. https:\/\/doi.org\/10.3892\/ijmm.2025.5664.","journal-title":"Int J Mol Med"},{"issue":"8","key":"1521_CR129","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/biom11081224","volume":"11","author":"O Wongmekiat","year":"2021","unstructured":"Wongmekiat O, et al. Protective effects of purple rice husk against diabetic nephropathy by modulating PGC-1\u03b1\/SIRT3\/SOD2 signaling and maintaining mitochondrial redox equilibrium in rats. Biomolecules. 2021;11(8):1224.","journal-title":"Biomolecules"},{"issue":"17","key":"1521_CR130","doi-asserted-by":"publisher","first-page":"13502","DOI":"10.3390\/ijms241713502","volume":"24","author":"C Wu","year":"2023","unstructured":"Wu C, et al. Single-cell transcriptional landscape reveals the regulatory network and its heterogeneity of renal mitochondrial damages in diabetic kidney disease. Int J Mol Sci. 2023;24(17):13502.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1521_CR131","first-page":"539","volume":"13","author":"T Wu","year":"2023","unstructured":"Wu T, et al. The mechanism of hyperglycemia-induced renal cell injury in diabetic nephropathy disease: an update. Life (Basel). 2023;13(2):539.","journal-title":"Life (Basel)"},{"key":"1521_CR132","doi-asserted-by":"publisher","first-page":"157182","DOI":"10.1016\/j.phymed.2025.157182","volume":"147","author":"Y Wu","year":"2025","unstructured":"Wu Y, et al. The natural compound stachyose targets SGLT2-mediated metabolic reprogramming to ameliorate diabetic kidney disease. Phytomedicine. 2025;147:157182.","journal-title":"Phytomedicine"},{"key":"1521_CR133","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","volume":"11","author":"L Xiao","year":"2017","unstructured":"Xiao L, et al. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1. Redox Biol. 2017;11:297\u2013311.","journal-title":"Redox Biol"},{"issue":"1","key":"1521_CR134","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ymthe.2025.10.009","volume":"34","author":"Y Xiong","year":"2026","unstructured":"Xiong Y, et al. PAD4 promotes macrophage migration to aggravate tubulointerstitial injury in diabetic kidney disease. Mol Ther. 2026;34(1):511\u201326.","journal-title":"Mol Ther"},{"key":"1521_CR135","doi-asserted-by":"publisher","first-page":"872918","DOI":"10.3389\/fendo.2022.872918","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Xu G. Update on pathogenesis of glomerular hyperfiltration in early diabetic kidney disease. Front Endocrinol (Lausanne). 2022;13:872918.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1521_CR136","doi-asserted-by":"publisher","first-page":"707006","DOI":"10.3389\/fphar.2021.707006","volume":"12","author":"Q Yang","year":"2021","unstructured":"Yang Q, et al. SS31 ameliorates podocyte injury via inhibiting OMA1-mediated hydrolysis of OPA1 in diabetic kidney disease. Front Pharmacol. 2021;12:707006.","journal-title":"Front Pharmacol"},{"key":"1521_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043807","author":"KJ Yang","year":"2023","unstructured":"Yang KJ, et al. Inhibition of xanthine oxidase protects against diabetic kidney disease through the amelioration of oxidative stress via VEGF\/VEGFR axis and NOX-FoxO3a-eNOS signaling pathway. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043807.","journal-title":"Int J Mol Sci"},{"key":"1521_CR138","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jare.2024.09.021","volume":"74","author":"Y Yang","year":"2025","unstructured":"Yang Y, et al. DeSUMOylation of RBMX regulates exosomal sorting of cargo to promote renal tubulointerstitial fibrosis in diabetic kidney disease. J Adv Res. 2025;74:175\u201389.","journal-title":"J Adv Res"},{"issue":"3","key":"1521_CR139","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/CS20258557","volume":"140","author":"WX Yang","year":"2026","unstructured":"Yang WX, et al. Intrarenal renin-angiotensin system inactivation ameliorates tubulopathy via attenuation of mitochondrial oxidative stress, dysfunction and senescence in diabetes. Clin Sci (Lond). 2026;140(3):321\u201338.","journal-title":"Clin Sci (Lond)"},{"key":"1521_CR140","doi-asserted-by":"publisher","first-page":"155195","DOI":"10.1016\/j.metabol.2022.155195","volume":"131","author":"L Yao","year":"2022","unstructured":"Yao L, et al. Mitochondrial dysfunction in diabetic tubulopathy. Metabolism. 2022;131:155195.","journal-title":"Metabolism"},{"key":"1521_CR141","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2026.03.052","volume":"250","author":"S Yao","year":"2026","unstructured":"Yao S, et al. CAP1 deficiency protects podocytes in diabetic kidney disease by reducing mitochondria-associated endoplasmic reticulum membrane formation and mitochondrial fission. Free Radic Biol Med. 2026;250:116\u201333.","journal-title":"Free Radic Biol Med"},{"key":"1521_CR142","doi-asserted-by":"publisher","first-page":"1006137","DOI":"10.3389\/fimmu.2022.1006137","volume":"13","author":"Z Ye","year":"2022","unstructured":"Ye Z, et al. Immune repertoire and evolutionary trajectory analysis in the development of diabetic nephropathy. Front Immunol. 2022;13:1006137.","journal-title":"Front Immunol"},{"key":"1521_CR143","doi-asserted-by":"publisher","first-page":"103435","DOI":"10.1016\/j.redox.2024.103435","volume":"78","author":"S Ye","year":"2024","unstructured":"Ye S, et al. YAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease. Redox Biol. 2024;78:103435.","journal-title":"Redox Biol"},{"key":"1521_CR144","doi-asserted-by":"publisher","first-page":"883057","DOI":"10.3389\/fphar.2022.883057","volume":"13","author":"X Yi","year":"2022","unstructured":"Yi X, et al. Erythropoietin mitigates diabetic nephropathy by restoring PINK1\/Parkin-mediated mitophagy. Front Pharmacol. 2022;13:883057.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1521_CR145","doi-asserted-by":"publisher","first-page":"F301","DOI":"10.1152\/ajprenal.00266.2023","volume":"326","author":"N Youssef","year":"2024","unstructured":"Youssef N, et al. Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progression. Am J Physiol Renal Physiol. 2024;326(3):F301-f312.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1521_CR146","doi-asserted-by":"publisher","first-page":"1549484","DOI":"10.3389\/fimmu.2025.1549484","volume":"16","author":"W Yu","year":"2025","unstructured":"Yu W, et al. Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies. Front Immunol. 2025;16:1549484.","journal-title":"Front Immunol"},{"issue":"5","key":"1521_CR147","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41419-020-2481-5","volume":"11","author":"Q Yuan","year":"2020","unstructured":"Yuan Q, et al. Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation. Cell Death Dis. 2020;11(5):355.","journal-title":"Cell Death Dis"},{"issue":"7","key":"1521_CR148","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/stem.3375","volume":"39","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, et al. Mitochondrial transfer from mesenchymal stem cells to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC-1\u03b1 activation. Stem Cells. 2021;39(7):913\u201328.","journal-title":"Stem Cells"},{"key":"1521_CR149","doi-asserted-by":"publisher","first-page":"114342","DOI":"10.1016\/j.intimp.2025.114342","volume":"152","author":"R Yue","year":"2025","unstructured":"Yue R, et al. Inhibition of Drp1-mediated mitochondrial fission by P110 ameliorates renal injury in diabetic nephropathy. Int Immunopharmacol. 2025;152:114342.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1521_CR150","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1681\/ASN.2014050457","volume":"26","author":"M Zhan","year":"2015","unstructured":"Zhan M, et al. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. J Am Soc Nephrol. 2015;26(6):1304\u201321.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1521_CR151","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000530485","volume":"9","author":"L Zhang","year":"2023","unstructured":"Zhang L, et al. From physiology to pathology: the role of mitochondria in acute kidney injuries and chronic kidney diseases. Kidney Dis (Basel). 2023;9(5):342\u201357.","journal-title":"Kidney Dis (Basel)"},{"key":"1521_CR152","doi-asserted-by":"publisher","first-page":"155377","DOI":"10.1016\/j.metabol.2022.155377","volume":"139","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease. Metabolism. 2023;139:155377.","journal-title":"Metabolism"},{"issue":"36","key":"1521_CR153","doi-asserted-by":"publisher","first-page":"e2405325","DOI":"10.1002\/advs.202405325","volume":"11","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. Forkhead Box Protein K1 promotes chronic kidney disease by driving glycolysis in tubular epithelial cells. Adv Sci (Weinh). 2024;11(36):e2405325.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"1521_CR154","doi-asserted-by":"publisher","first-page":"2484632","DOI":"10.1080\/0886022X.2025.2484632","volume":"47","author":"J Zhang","year":"2025","unstructured":"Zhang J, et al. miR-1225-3p regulates fibrosis in mesangial cells via SMURF2-mediated ubiquitination of ChREBP in diabetic kidney disease. Ren Fail. 2025;47(1):2484632.","journal-title":"Ren Fail"},{"issue":"4","key":"1521_CR155","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.7150\/thno.50905","volume":"11","author":"M Zhao","year":"2021","unstructured":"Zhao M, et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics. 2021;11(4):1845\u201363.","journal-title":"Theranostics"},{"issue":"1","key":"1521_CR156","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1038\/s41467-025-62890-9","volume":"16","author":"H Zhao","year":"2025","unstructured":"Zhao H, et al. Branched-chain amino acids contribute to diabetic kidney disease progression via PKM2-mediated podocyte metabolic reprogramming and apoptosis. Nat Commun. 2025;16(1):7846.","journal-title":"Nat Commun"},{"issue":"7","key":"1521_CR157","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41419-019-1754-3","volume":"10","author":"D Zhou","year":"2019","unstructured":"Zhou D, et al. PGRN acts as a novel regulator of mitochondrial homeostasis by facilitating mitophagy and mitochondrial biogenesis to prevent podocyte injury in diabetic nephropathy. Cell Death Dis. 2019;10(7):524.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1521_CR158","doi-asserted-by":"publisher","first-page":"e70332","DOI":"10.1096\/fj.202403014R","volume":"39","author":"S Zhu","year":"2025","unstructured":"Zhu S, et al. m6A demethylase Fto inhibited macrophage activation and glycolysis in diabetic nephropathy via m6A\/Npas2\/Hif-1\u03b1 axis. FASEB J. 2025;39(2):e70332.","journal-title":"FASEB J"},{"issue":"3","key":"1521_CR159","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909\u201350.","journal-title":"Physiol Rev"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01521-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:01:57Z","timestamp":1786683717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01521-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01521-5","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"128"}}